Well Health Technologies Stock Return On Equity

WELL Stock  CAD 5.17  0.03  0.58%   
WELL Health Technologies fundamentals help investors to digest information that contributes to WELL Health's financial success or failures. It also enables traders to predict the movement of WELL Stock. The fundamental analysis module provides a way to measure WELL Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to WELL Health stock.
Last ReportedProjected for Next Year
As of the 22nd of November 2024, Return On Equity is likely to drop to 0.0001.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

WELL Health Technologies Company Return On Equity Analysis

WELL Health's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.

Return On Equity

 = 

Net Income

Total Equity

More About Return On Equity | All Equity Analysis

Current WELL Health Return On Equity

    
  0.11  
Most of WELL Health's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, WELL Health Technologies is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

WELL Return On Equity Driver Correlations

Understanding the fundamental principles of building solid financial models for WELL Health is extremely important. It helps to project a fair market value of WELL Stock properly, considering its historical fundamentals such as Return On Equity. Since WELL Health's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of WELL Health's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of WELL Health's interrelated accounts and indicators.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Competition

WELL Total Stockholder Equity

Total Stockholder Equity

806.05 Million

At this time, WELL Health's Total Stockholder Equity is very stable compared to the past year.
Based on the latest financial disclosure, WELL Health Technologies has a Return On Equity of 0.1089. This is 100.45% lower than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The return on equity for all Canada stocks is 135.13% lower than that of the firm.

WELL Return On Equity Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses WELL Health's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of WELL Health could also be used in its relative valuation, which is a method of valuing WELL Health by comparing valuation metrics of similar companies.
WELL Health is currently under evaluation in return on equity category among its peers.

WELL Health Current Valuation Drivers

We derive many important indicators used in calculating different scores of WELL Health from analyzing WELL Health's financial statements. These drivers represent accounts that assess WELL Health's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of WELL Health's important valuation drivers and their relationship over time.
201920202021202220232024 (projected)
Market Cap151.2M1.1B937.3M626.8M910.7M956.2M
Enterprise Value154.7M1.0B1.3B936.3M1.3B1.4B

WELL Fundamentals

About WELL Health Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze WELL Health Technologies's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of WELL Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of WELL Health Technologies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Other Information on Investing in WELL Stock

WELL Health financial ratios help investors to determine whether WELL Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in WELL with respect to the benefits of owning WELL Health security.